Seems to be contradictory, a latest study in prostate cancer reported that KLF5 inhibited angiogenesis in PTEN-deficient prostate cancer by attenuating Akt activation and subsequent HIF1-maintained VEGFA expression [22]. This evidence concerns the gene KLF5 and prostate cancer.